Fifteen years gives a strong business plenty of time to become something much larger.

That is the sort of opportunity I would be looking for. I want companies that are already proving themselves today but still have several ways to grow from here.

These are three ASX shares I would be happy to buy with that timeframe in mind.

Pro Medicus Ltd (ASX: PME)

Pro Medicus has already become an important provider of medical imaging software to major healthcare systems, particularly in the US.

But despite winning some very large customers, the company estimates it still has only around 11% of the US market.

I think that leaves a substantial opportunity ahead.

Visage has already shown that it can handle the demands of large hospital networks, so Pro Medicus can keep taking that proven technology to more healthcare organisations over the years ahead.

There is also room to do more within existing customers. The company is expanding beyond radiology into cardiology and enterprise imaging, which could allow Visage to handle a greater share of the medical images produced across a healthcare system.

Medical imaging volumes should also keep rising as populations age and healthcare becomes more reliant on scans. Artificial intelligence could make the platform even more valuable as hospitals look for better ways to analyse those images and manage growing workloads.

With so much of the US market still available, I think Pro Medicus has plenty of room to keep growing for years.

Hub24 Ltd (ASX: HUB)

Hub24 has built an important position in Australia’s wealth management industry.

Its investment platform helps financial advisers manage client portfolios and superannuation, putting the company behind a growing amount of Australian household wealth.

Hub24 has been expanding the technology available to advisers through businesses such as Class and myprosperity. That gives it more ways to help advice practices with administration, reporting, client engagement, and other everyday tasks.

The more of that work Hub24 can handle, the more important its technology can become to advisers.

Australia’s superannuation system provides another long-term tailwind. Workers keep contributing throughout their careers, while investment returns can increase the value of existing savings.

Hub24 therefore has the chance to win a larger share of a market that itself should continue growing.

If it keeps improving its technology and strengthening adviser relationships, I think the business could look considerably larger by the early 2040s.

Life360 Inc. (ASX: 360)

Life360 is an ASX share that has built a service that millions of families use as part of everyday life.

Location sharing remains at the centre of the platform, but I think the longer-term opportunity comes from how many other family safety needs can be addressed around that relationship.

The company has already expanded into driving safety, emergency assistance, identity protection, connected devices, pets, and services aimed at ageing family members.

Growing the number of paid subscribers remains an important part of the story, including converting more free users over time. But I see that as one part of a wider opportunity to make Life360 more valuable to each household.

International growth could also become increasingly important.

Life360 already has users across a huge number of countries, giving it the chance to build stronger businesses outside the US as awareness and adoption increase.

If the company keeps finding practical ways to help families protect the people and things they care about, I think it could become a much more substantial consumer technology platform over the next 15 years.

Foolish takeaway

A 15-year investment does not need every year to go smoothly.

What I want is enough time for strong businesses to develop new products, enter larger markets, deepen customer relationships, and keep building on what they have already achieved.

I think Pro Medicus, Hub24, and Life360 all have that sort of runway.

That is why I would be comfortable buying all three today and giving their long-term opportunities plenty of time to develop.

The post 3 ASX shares I’d buy for the next 15 years appeared first on The Motley Fool Australia.

More reading

• Buy, hold, sell: Pro Medicus, Fortescue, CBA shares
• ASX 200 healthcare shares soar 9% amid notable FY26 reports from CSL, Pro Medicus
• How I’d use ASX growth shares to build long-term wealth
• Why Guzman Y Gomez, Pro Medicus and James Hardie shares are turning heads on Friday
• Pro Medicus signs A$25m US contract: What it means for investors

Motley Fool contributor Grace Alvino has positions in Hub24. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Hub24 and Life360. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool Australia has recommended Hub24 and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Commonwealth Bank of Australia (ASX: CBA) shares are back in the green on Wednesday after the banking giant announced a deal to settle a long-running class action.

At the time of writing, the CBA share price is up 0.92% to $158.47.

It has been a much tougher month for shareholders, with the stock down around 8% over that period. CBA shares are also roughly flat since the start of 2026 and remain around 15% below their 52-week high of $185.59.

Still, investors appear comfortable with today’s announcement, with shares moving higher in morning trade.

Let’s take a closer look at the release.

CBA reaches $249 million settlement

CBA said this morning that it has reached an in-principle agreement to settle a class action involving the bank, Colonial First State Investments and Avanteos Investments.

The proposed settlement is worth $249 million and still needs to be finalised and approved by the Federal Court of Australia.

The proceedings were launched in 2018 by Slater and Gordon on behalf of class members.

They relate to certain cash and deposit options issued by CBA and offered through Colonial First State superannuation and wrap products between November 2008 and September 2021.

However, CBA, Colonial First State Investments and Avanteos Investments deny the allegations and have made no admission of liability or wrongdoing.

If the court approves the deal, eligible class members could receive a share of the settlement after legal fees and other costs are deducted.

Why are CBA shares higher?

A $249 million settlement does sound sizeable, but there’s a key detail in the above announcement.

CBA said the proposed settlement is already covered by a provision recognised in an earlier period. 

That means investors aren’t looking at a new $249 million hit to current earnings, which likely helps explain why the share price has moved higher today.

The announcement also comes shortly after CBA reported another strong full-year result.

Cash net profit after tax rose 7% to $10.98 billion in FY26, while statutory profit increased 8% to $10.91 billion.

The bank also lifted its final dividend to $2.70 per share, taking the fully-franked full-year payout to $5.05 per share.

What next for CBA shares?

Today’s rise is welcome for shareholders, but CBA shares still have ground to recover after falling around 8% this month.

The bank is also trading much closer to its 52-week low of $146.98 than the record levels it reached earlier this year.

Even after that pullback, CBA shares are not exactly cheap, trading on a P/E ratio of around 24. That still leaves the bank at a fairly high valuation compared with the other major banks.

The focus now is on whether CBA shares can keep moving higher after a difficult few weeks.

The post CBA shares bounce after settling long-running class action appeared first on The Motley Fool Australia.

More reading

• Will CBA shares ever get back to the top of the ASX 200?
• Buy, hold, sell: DigiCo Infrastructure REIT, CBA, Telstra shares
• How many CBA shares do I need to buy for $8,000 of passive income?
• Buy, hold, sell: Pro Medicus, Fortescue, CBA shares
• Are Westpac shares a buy at their new 52-week low?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX retail stock Lovisa Holdings Ltd (ASX: LOV) is rocketing 19% to $29.22 on Wednesday morning, taking its monthly gain to 35%.

Despite the surge, the jewellery retailer remains 22% lower over the past 12 months, while the S&P/ASX 200 Index (ASX: XJO) has gained around 2%.

So, what’s driving today’s dramatic rebound?

Lovisa delivers another strong year

Investors are responding to a solid full-year result, with Lovisa delivering growth across its key financial metrics. Total revenue increased 17.6% to $938.8 million, while comparable-store sales rose 2.0%.

The ASX retail stock also lifted earnings before interest and tax (EBIT) by 14.1% to $158.2 million. Net profit after tax climbed 10.7% to $95.6 million.

Lovisa generated $294.5 million in operating cash flow, up 21.0%, demonstrating the company’s ability to fund its expansion while continuing to generate substantial cash.

Shareholders also received a boost, with the full-year dividend increasing 11.7% to 86 cents per share.

Global expansion remains a key growth driver

Lovisa continued its aggressive international expansion during the year, opening 160 new stores and finishing with 1,136 stores across more than 50 markets. Europe was the standout region for store growth, with 76 new locations added, including 34 in the UK and 20 in Germany.

However, management isn’t simply opening stores for the sake of growth. Lovisa closed 43 underperforming locations and relocated another 12, highlighting its focus on improving store profitability and optimising its global network.

The ASX retail stock also continued investing in technology, its supply chain, and global retail operations. Importantly, Lovisa said these investments were fully funded by existing cash flows.

What did Lovisa management say?

Lovisa Global Chief Executive Officer John Cheston said:

Lovisa has once again been able to deliver strong global sales and profit growth, with the highlights being continued growth in the Americas and Europe and another exceptional Gross Margin performance.

What’s next for Lovisa shares?

The early signs from FY27 are encouraging. Lovisa reported total sales growth of 16.4% on a constant-currency basis during the first eight weeks, while comparable-store sales increased 3.0%.

The retailer plans to continue expanding its physical and digital presence, supported by its strong balance sheet and steady cash generation.

After a 22% decline over the past year, today’s 19% rally of the ASX retail stock suggests investors are reassessing Lovisa’s growth prospects.

Whether the recovery can continue, however, will depend on the company maintaining strong comparable-store growth while successfully scaling its rapidly expanding international footprint.

The post Why is this $3 billion ASX retail stock rocketing 19% today? appeared first on The Motley Fool Australia.

More reading

• Lovisa Holdings FY26 earnings: Profit and sales keep growing
• A rare buying opportunity in 1 of Australia’s top shares?
• How much is needed in superannuation to target a $5,500 monthly passive income?
• 7 ASX 200 shares downgraded by the experts this week
• 2 top ASX shares to buy and hold for the next decade

Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Lovisa. The Motley Fool Australia has recommended Lovisa. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.